These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 30654078
1. Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials. Wan MT, Torigian DA, Alavi A, Alvarez J, Chiesa Fuxench ZC, Noe MH, Papadopoulos M, Shin DB, Takeshita J, Werner TJ, Mehta NN, Gelfand JM. J Am Acad Dermatol; 2019 Jun; 80(6):1630-1639. PubMed ID: 30654078 [Abstract] [Full Text] [Related]
2. Prevalence of non 18 F-fluorodeoxyglucose-avid incidental findings of clinical significance on whole body positron emission tomography/computed tomography: A review of 500 consecutive cases. Sheldon JA, Yap KK, Taubman KL, Schlicht SM. J Med Imaging Radiat Oncol; 2018 Apr; 62(2):194-202. PubMed ID: 29230956 [Abstract] [Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019 Apr; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
4. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation. Hagenimana N, Dallaire J, Vallée É, Belzile M. J Otolaryngol Head Neck Surg; 2017 Mar 21; 46(1):22. PubMed ID: 28320460 [Abstract] [Full Text] [Related]
5. Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study using 18F-fluorodeoxyglucose PET/CT. Kim BS, Lee WK, Pak K, Han J, Kim GW, Kim HS, Ko HC, Kim MB, Kim SJ. J Am Acad Dermatol; 2019 May 21; 80(5):1322-1331. PubMed ID: 29559399 [Abstract] [Full Text] [Related]
6. Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 Patients. Lebech AM, Gaardsting A, Loft A, Graff J, Markova E, Bertelsen AK, Madsen JL, Andersen KF, Benzon EV, Helms M, Mathiesen LR, David KP, Kronborg G, Kjaer A. J Nucl Med; 2017 Jul 21; 58(7):1058-1064. PubMed ID: 28082437 [Abstract] [Full Text] [Related]
7. 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography can reliably rule-out infection and cancer in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis suspected of disease relapse. Frary EC, Hess S, Gerke O, Laustrup H. Medicine (Baltimore); 2017 Jul 21; 96(30):e7613. PubMed ID: 28746217 [Abstract] [Full Text] [Related]
8. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values. Kao YH, Lim SS, Ong SC, Padhy AK. Can Assoc Radiol J; 2012 Nov 21; 63(4):289-93. PubMed ID: 22136969 [Abstract] [Full Text] [Related]
9. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study. Rivers JP, Powell-Wiley TM, Dey AK, Rodante JA, Chung JH, Joshi AA, Natarajan B, Sajja AP, Chaturvedi A, Rana A, Harrington CL, Teague HL, Lockshin BN, Ahlman MA, Yao J, Playford MP, Gelfand JM, Mehta NN. JACC Cardiovasc Imaging; 2018 Feb 21; 11(2 Pt 2):349-357. PubMed ID: 29055628 [Abstract] [Full Text] [Related]
10. Incidence and Economic Impact of Incidental Findings on 18F-FDG PET/CT Imaging. Adams SJ, Rakheja R, Bryce R, Babyn PS. Can Assoc Radiol J; 2018 Feb 21; 69(1):63-70. PubMed ID: 29458956 [Abstract] [Full Text] [Related]
11. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen-Auerbach M, Schiepers C, Herrmann K. Nucl Med Commun; 2016 Dec 21; 37(12):1290-1296. PubMed ID: 27612034 [Abstract] [Full Text] [Related]
12. Role of 18F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer Patients. Piccardo A, Trimboli P, Puntoni M, Foppiani L, Treglia G, Naseri M, Bottoni GL, Massollo M, Sola S, Ferrarazzo G, Bruzzone M, Catrambone U, Arlandini A, Paone G, Ceriani L, Cabria M, Giovanella L. Thyroid; 2019 Apr 21; 29(4):549-556. PubMed ID: 30864903 [Abstract] [Full Text] [Related]
13. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation? Reesink DJ, Fransen van de Putte EE, Vegt E, De Jong J, van Werkhoven E, Mertens LS, Bex A, van der Poel HG, van Rhijn BW, Horenblas S, Meijer RP. J Urol; 2016 Apr 21; 195(4 Pt 1):907-12. PubMed ID: 26598424 [Abstract] [Full Text] [Related]
14. Focal Thyroid Incidentalomas on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration. de Leijer JF, Metman MJH, van der Hoorn A, Brouwers AH, Kruijff S, van Hemel BM, Links TP, Westerlaan HE. Front Endocrinol (Lausanne); 2021 Apr 21; 12():723394. PubMed ID: 34744999 [Abstract] [Full Text] [Related]
15. Thyroid Incidentalomas Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography: Malignant Risk Stratification and Management Plan. Chung SR, Choi YJ, Suh CH, Kim HJ, Lee JJ, Kim WG, Sung TY, Lee YM, Song DE, Lee JH, Baek JH. Thyroid; 2018 Jun 21; 28(6):762-768. PubMed ID: 29759033 [Abstract] [Full Text] [Related]
16. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values. Brindle R, Mullan D, Yap BK, Gandhi A. Eur J Surg Oncol; 2014 Nov 21; 40(11):1528-32. PubMed ID: 24915858 [Abstract] [Full Text] [Related]
17. Clinical value of 18F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer. Caspersen KB, Giannoutsou N, Gerke O, Alavi A, Høilund-Carlsen PF, Hess S. Ann Nucl Med; 2019 Mar 21; 33(3):184-192. PubMed ID: 30569441 [Abstract] [Full Text] [Related]
18. Breast incidentalomas on 18-Fluorodeoxyglucose positron emission tomography-computed tomography performed for a non-mammary cause: Significance and outcomes. Menon P, Bourke A. J Med Imaging Radiat Oncol; 2023 Jun 21; 67(4):357-364. PubMed ID: 36468633 [Abstract] [Full Text] [Related]
19. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study. Shmidt E, Nehra V, Lowe V, Oxentenko AS. BMC Gastroenterol; 2016 Oct 06; 16(1):125. PubMed ID: 27716085 [Abstract] [Full Text] [Related]
20. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM. Arch Dermatol; 2011 Sep 06; 147(9):1031-9. PubMed ID: 21576552 [Abstract] [Full Text] [Related] Page: [Next] [New Search]